PSYENCE BIOMEDICAL LTD.

Over the last 90 days, PBM has reported zero cyber incidents and zero material red-flag 8-K filings, suggesting operational stability in the near term. However, a short observation window provides limited visibility into structural risks—particularly dilution exposure and capital raise patterns that accumulate over longer periods. The full $49 Report extends analysis to twelve months, adds dilution risk scoring, maps financing history, flags AI-detected anomalies in SEC filings, and contextualizes any 8-K activity within the company's broader trajectory. The full $49 Report adds the dilution snapshot, 12-month event timeline, and risk signals that a 90-day window cannot capture.